Cynosure Group LLC Acquires 4,344,817 Shares of GE HealthCare Technologies Inc. $GEHC

Cynosure Group LLC boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21,045.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,365,462 shares of the company’s stock after buying an additional 4,344,817 shares during the quarter. GE HealthCare Technologies accounts for 16.6% of Cynosure Group LLC’s holdings, making the stock its 2nd largest position. Cynosure Group LLC’s holdings in GE HealthCare Technologies were worth $358,055,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in GEHC. Norges Bank acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $596,024,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $533,655,000. Capital Research Global Investors raised its stake in GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Dodge & Cox raised its stake in GE HealthCare Technologies by 16.8% during the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares during the period. Finally, Boston Partners acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $287,627,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have issued reports on GEHC shares. Barclays cut their target price on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 30th. BTIG Research cut their target price on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their target price for the company from $75.00 to $69.00 in a research note on Thursday, May 21st. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Finally, Wells Fargo & Company cut their target price on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $80.21.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CFO James Saccaro purchased 3,310 shares of the stock in a transaction dated Friday, May 1st. The shares were acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 21,847 shares of company stock worth $1,361,355 over the last 90 days. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Trading Down 0.6%

GE HealthCare Technologies stock opened at $64.76 on Tuesday. The company’s fifty day simple moving average is $66.21 and its 200-day simple moving average is $75.07. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The stock has a market cap of $29.46 billion, a P/E ratio of 15.49, a P/E/G ratio of 1.47 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the prior year, the firm earned $1.01 earnings per share. The company’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.